Overview of new antiobesity drugs.

Abstract

A short overview of new drugs approved for the treatment of obesity (lorcaserin, phentermine/topiramate combination) as well as those with a perspective for approval as antiobesity drugs (cetilistat, naltrexone/bupropion combination, liraglutide) is presented. All these drugs produce significant weight loss accompanied by reductions in cardiometabolic… (More)
DOI: 10.1517/14656566.2014.946904

Topics

Cite this paper

@article{Hainer2014OverviewON, title={Overview of new antiobesity drugs.}, author={Vojtěch Hainer}, journal={Expert opinion on pharmacotherapy}, year={2014}, volume={15 14}, pages={1975-8} }